TD SYNNEX (SNX) director Richard Hume sells 5,000 shares via 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TD SYNNEX CORP director Richard T. Hume reported selling a total of 5,000 shares of common stock on June 2, 2026. The sales were executed in multiple open-market trades at prices roughly between $278 and $286 per share.
The filing notes these transactions were carried out under a Rule 10b5-1 trading plan adopted on February 2, 2026, indicating they were pre-scheduled rather than timed discretely to market events.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 5,000 shares ($1,401,894)
Net Sell
11 txns
Insider
HUME RICHARD T
Role
null
Sold
5,000 shs ($1.40M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 21 | $272.75 | $6K |
| Sale | Common Stock | 28 | $276.50 | $8K |
| Sale | Common Stock | 60 | $277.90 | $17K |
| Sale | Common Stock | 725 | $278.56 | $202K |
| Sale | Common Stock | 2,230 | $279.50 | $623K |
| Sale | Common Stock | 477 | $280.25 | $134K |
| Sale | Common Stock | 399 | $281.35 | $112K |
| Sale | Common Stock | 303 | $282.38 | $86K |
| Sale | Common Stock | 478 | $283.55 | $136K |
| Sale | Common Stock | 191 | $284.66 | $54K |
| Sale | Common Stock | 88 | $285.26 | $25K |
Holdings After Transaction:
Common Stock — 28,516 shares (Direct, null)
Footnotes (1)
- These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2026. Represents the weighted average sales price for a number of transactions effected at prices ranging from $277.895 to $277.95. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $278.08 to $278.97. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $279.005 to $279.99. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $280.005 to $280.75. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $281.08 to $281.995. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $282.10 to $282.875. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $283.01 to $283.96. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $284.00 to $284.995. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price for a number of transactions effected at prices ranging from $285.045 to $285.575. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
Key Figures
Shares sold: 5,000 shares
Number of sale transactions: 11 transactions
Example sale price: $279.50 per share
+5 more
8 metrics
Shares sold
5,000 shares
Total common shares sold on June 2, 2026
Number of sale transactions
11 transactions
Separate open-market sales of common stock
Example sale price
$279.50 per share
One reported transaction price for common stock
Lowest referenced range
$277.895–$277.95
Weighted-average price range in one footnote
Highest referenced range
$285.045–$285.575
Weighted-average price range in one footnote
10b5-1 plan adoption date
February 2, 2026
Date Hume adopted the Rule 10b5-1 trading plan
Transaction date
June 2, 2026
Date of reported open-market sales
Net share direction
5,000-share net sale
Net change across all reported transactions
Key Terms
Rule 10b5-1 trading plan, open-market sale, weighted average sales price, non-derivative, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action: open-market sale; transaction_code_description: Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average sales price financial
"Represents the weighted average sales price for a number of transactions effected at prices ranging from..."
non-derivative financial
"transaction_type: non-derivative for Common Stock transactions"
Form 4 regulatory
"INSIDER FILING DATA (Form 4): { "issuerName": "TD SYNNEX CORP"..."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did TD SYNNEX (SNX) report for Richard T. Hume?
TD SYNNEX reported that director Richard T. Hume sold 5,000 shares of common stock. The transactions occurred on June 2, 2026 through multiple open-market sales, as disclosed in a Form 4 insider trading report.
How many separate sale transactions did Richard T. Hume execute in TD SYNNEX stock?
The Form 4 shows 11 separate sale transactions in TD SYNNEX common stock. Each transaction reflects a distinct block of shares sold in the open market at different prices during trading on June 2, 2026.
Was the TD SYNNEX (SNX) insider sale by Richard T. Hume under a Rule 10b5-1 plan?
Yes. A footnote states the sales were effectuated under a Rule 10b5-1 trading plan adopted on February 2, 2026. Such plans pre-schedule trades, which can make their timing less indicative of the insider’s short-term market view.
Did Richard T. Hume’s TD SYNNEX transactions involve derivatives or only common stock?
The disclosed transactions involve only non-derivative common stock. The derivative section of the Form 4 shows no derivative transactions or remaining derivative positions associated with these June 2, 2026 trades.